Janux Therapeutics Inc - fluxo de caixa trimestral (NASDAQ:JANX) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -16.73 M-17.02 M-23.81 M-12.86 M-28.54 M -82.23 M Cash from investing activities 33.93 M-340.39 M1.56 M8.31 M29.54 M -300.98 M Cash from financing activities 386.65 M554 K954 K493 K2.94 M 4.95 M Free cash flow -16.77 M-17.39 M-24.29 M-12.95 M-28.65 M -83.28 M

Notícias

UBS rebaixa classificação das ações da Janux Therapeutics após dados de ensaio clínico

Truist reduz preço-alvo da Janux Therapeutics devido à concorrência

Truist cuts Janux Therapeutics stock price target on competition

Janux therapeutics doses first participant in JANX011 phase 1 trial

Vir Biotechnology Stock: The Low-Down On The Readouts Ahead (NASDAQ:VIR)

Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?

Janux Therapeutics nomeia William Go como novo diretor médico

Janux Therapeutics appoints William Go as new chief medical officer

Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion (BMY)

JANX Enters Global Oncology Collaboration With BMY, Stock Rises

Ações da Janux sobem após acordo de colaboração com Bristol Myers Squibb

Janux stock rises after Bristol Myers Squibb collaboration deal